Venetoclax
abbvie,roche
['leukemia', 'myeloid', 'toci', 'rova,(-approval)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'rova,(-approval),(-microvascular)', 'leusm', 'mds', 'gilead']
#ash22 #leusm daver: real world outcomes with newly dx d aml with tp53mut or chr17 deletion. used flatiron db. n=370 overall. low allohct rates (5% with hma+/-ven, 16% with intensive chemo). 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)